Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours

Journal of Photochemistry and Photobiology B: Biology

Volumn 37, Issue 3, 1997, Pages 189-195

  Reddi, Elena ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Liposomes; Low density lipoproteins; Monoclonal antibodies; Pharmacokinetics; Photodynamic therapy; Photosensitizers

Indexed keywords

ANTIBODY CONJUGATE; DRUG VEHICLE; INTRALIPID; LIPOSOME; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; PHOTOSENSITIZING AGENT;

ARTICLE; CANCER THERAPY; DRUG DISTRIBUTION; DRUG UPTAKE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0031081811     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07404-0     Document Type: Review

References (50)

1. [1] T.J. Dougherty, Photosensitizers, therapy and detection of malignant tumors, Photochem. Photobiol., 45 (1987) 879-889.
2. [2] D.A. Bellnier, Y.-K. Ho, R.K. Pandey, J.R. Missert and T.J. Dougherty, Distribution and elimination of Photofrin II in mice, Photochem. Photobiol., 50 (1989) 221-228.
3. [3] A.R. Oseroff, G. Ara, D. Ohuoha, J. Aprille, J.C. Bommer, M.L. Yarmush, J. Foley and L. Cincotta, Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysis, Photochem. Photobiol., 46 (1987) 83-96.
4. [4] G. Jori, E. Reddi, I. Cozzani and L. Tomio, Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice, Br. J. Cancer, 53 (1986) 615-621.
5. [5] M.J. Hsu and R.L. Juliano, Interaction of liposomes with the reticuloendothelial system. II. Non specific and receptor mediated uptake of liposomes by mouse peritoneal macrophages, Biochim. Biophys. Acta, 720 (1982) 411-419.
6. [6] A. Segalla, E. Reddi and G. Jori, unpublished results, 1996.
7. [7] E. Reddi, C. Zhou, R. Biolo, E. Menegaldo and G. Jori, Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency, Br. J. Cancer, 61 (1990) 407-411.
8. [8] E. Reddi, S. Cernuschi, R. Biolo and G. Jori, Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours. III. Effect of cholesterol on pharmacokinetic and phototherapeutic properties. Lasers Med. Sci., 5 (1990) 339-343.
9. [9] K. Schieweck, H.-G. Capraro, U. Isele, P. van Hogevest, M. Ochsner, T. Maurer and E. Batt, CGP 55847, liposome-delivered zinc(II)-phthalocyanine as a phototherapeutic agent for tumours, in G. Jori, J. Moan and W.S. Start (eds.), Photodynamic Therapy of Cancer, Proc. SPIE, 2078 (1994) 148-157.
10. [10] L. Polo, G. Bianco, E. Reddi and G. Jori, The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoprotein, Int. J. Biochem. Cell Biol., 27 (1995) 1249-1255.
11. [11] E. Mayhew, L. Vanghan, A. Panus, M. Murray and B.W. Henderson, Lipid-associated methylpheophorbide-a-(hexyl-ether) as a photodynamic agent in tumour-bearing mice, Photochem. Photobiol., 58 (1993) 845-851.
12. [12] A.R. Morgan, G.M. Garbo, R.W. Keck and S.H. Selman, New photosensitizers for photodynamic therapy: combined effect of metallo purpurin derivatives and light on transplantable bladder tumors, Cancer Res., 48 (1988) 194-198.
13. [13] A.R. Morgan, G.M. Garbo, R.W. Keck and S.H. Selman, Hydrophobic versus hydrophilic drugs for PDT, in D.C. Neckers (ed.), New Directions in Photodynamic Therapy, Proc. SPIE, 847 (1987) 180-186.
14. [14] G.M. Garbo, The use of liposomes, emulsions or inclusion complexes may potentiate in vivo effects of SnET2, in T.J. Dougherty (ed.), Photodynamic Therapy: Mechanism II, Proc. SPIE, 1203 (1990) 118-125.
15. [15] K. Woodburn, C.K. Chang, S. Lee, B.W. Henderson and D. Kessel, Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle, Photochem. Photobiol., 60 (1994) 154-159.
16. [16] M. Soncin, L. Polo, E. Reddi, G. Jori, M.E. Kenny, S. Cheng and M.A.J. Rodgers, Effect of the delivery system on the biodistribution of Ge(IV)-octabutoxy-phthalocyanines in tumour-bearing mice, Cancer Lett., 89 (1995) 101-106.
17. [17] M. Soncin, L. Polo, E. Reddi, G. Jori, M.E. Kenny, S. Cheng and M.A.J. Rodgers, Effect of axial ligation and delivery system on the tumour-localizing and -photosensitizing properties of Ge(IV)-octabutoxy-phthalocyanines, Br. J. Cancer, 71 (1995) 727-732.
18. [18] M. Kongshaug, Distribution of tetrapyrrole photosensitizers among human plasma proteins, Int. J. Biochem., 24 (1992) 1239-1265.
19. [19] G. Jori, Pharmacokinetic studies with hematoporphyrin in tumour-bearing mice, in G. Jori and C. Perria (eds.), Photodynamic Therapy of Tumours and Other Diseases, Libreria Progetto, Padova, 1985, pp. 159-166.
20. [20] C. Zhou, C. Milanesi and G. Jori, An ultrastructural comparative evaluation of tumours photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins, Photochem. Photobiol. 48 (1988) 487-492.
21. [21] D. Kessel, P. Thompson, K. Saatio and K.D. Nantwi, Tumour localization and photosensitization by sulfonated derivatives of tetraphenylporphine, Photochem. Photobiol., 45 (1987) 787-790.
22. [22] M.S. Brown and J.L. Goldstein, A receptor-mediated pathway for cholesterol homeostasis, Science, 232 (1986) 34-47.
23. [23] P. Lombardi, G. Norata, F.M. Maggi, G. Canti, P. Franco, A. Nicolin and A.L. Catapano, Assimilation of LDL by experimental tumours in mice, Biochim. Biophys. Acta, 1003 (1989) 301-306.
24. [24] M.J. Rudling, B. Angelin, C.O. Peterson and V.P. Collins, Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement, Cancer Res., 50 (1990) 483-487.
25. [25] C. Peterson, M. Masquelier, M. Rudling, K. Söderberg and S. Vitols, Lipoproteins, malignancy and anticancer agents, in J.M. Shaw (ed.), Lipoproteins as Carriers of Pharmacological Agents, Marcel Dekker, New York, 1991, pp. 175-200.
26. [26] M.K. Bijsterbosch and T.J.C. van Berkel, Native and modified lipoproteins as drug delivery systems, Adv. Drug Deliv. Rev., 5 (1990) 231-251.
27. [27] S. Vitols, Uptake of low-density lipoprotein by malignant cells. Possible therapeutic applications, Cancer Cells, 3 (1991) 488-495.
28. [28] C. Candide, P. Morlière, J.C. Mazière, S. Goldstein, R. Santus, L. Dubertret, J.P. Reyftmann and J. Polonov, In vitro interaction of the photoactive anticancer porphyrin derivative Photofrin II with low-density lipoprotein and its delivery in cultured human fibroblasts, FEBS Lett., 207 (1986) 133-138.
29. [29] B.A. Allison, P.H. Pritchard, A.M. Richter and J.G. Levy, The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution, Photochem. Photobiol., 52 (1990) 501-507.
30. [30] B.A. Allison, E. Waterfield, A.M. Richter and J.G. Levy, The effect of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative, Photochem. Photobiol., 54 (1991) 709-715.
31. [31] C.A. Drevon, A.D. Attie, S.H. Pangburn and D. Steinberg, Metabolism of homologous and heterologous lipoproteins by cultured rat and human skin fibroblasts, J. Lipid Res., 22 (1981) 37-46.
32. [32] W.K.K. Ho and A.M. Leung, Binding of homologous versus heterologous low density lipoproteins by different tissues of the rat, Comp. Biochem. Physiol., 72B (1982) 547-549.
33. [33] M.J. Chapman, Comparative analysis of mammalian plasma lipoproteins, in J.P. Segrest and J.J. Albers (eds.), Methods in Enzymology, Academic Press, London, 1986, pp. 70-143.
34. [34] D. Mew, C.-K. Wat, G.H.N. Towers and J.G. Levy, Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates, J. Immunol., 130 (1983) 1473-1477.
35. [35] D. Mew, V. Lum, C.-K. Wat, G.H.N. Towers, G.-H.C. Sun, R.J. Walter, W. Wright, M.W. Berns and J.G. Levy, Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation, Cancer Res., 45 (1985) 4380-4386.
36. 6 conjugates, Proc. Natl. Acad. Sci. USA, 83 (1986) 8744-8748.
37. [37] T. Hasan, C.-W. Lin and A. Lin, Laser induced selective cytotoxicity using monoclonal antibody-chromophore conjugates, Prog. Clin. Biol. Res., 288 (1989) 471-477.
38. [38] T. Hasan, A. Lin, D. Yarmush, A.R. Oseroff and M. Yarmush, Monoclonal antibody-chromophore conjugates as selective phototoxins, J. Controlled Release, 10 (1989) 107-117.
39. [39] B.A. Goff, M. Bamberg and T. Hasan, Photoimmunotherapy of human ovarian carcinoma cells ex vivo, Cancer Res., 51 (1991) 4762-4767.
40. [40] B.A. Goff, U. Hermanto, J. Rumbaugh, J. Blake, M. Bamberg and T. Hasan, Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model, Br. J. Cancer, 70 (1994) 474-480.
41. [41] B.C. Schultes, S. Spaniol, S. Schmidt, W. Ertmer, H.-J. Biersack and D. Krebs, Photodynamic laser therapy with antibody-coupled phthalocyanine, in G. Jori, J. Moan and W.S. Start (eds.), Photodynamic Therapy of Cancer, Proc. SPIE, 2078 (1994) 148-157.
42. [42] J. Morgan, A.G. Gray and E.R. Huehns, Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitized liposomes directed to cells by monoclonal antibody in vitro, Br. J. Cancer, 59 (1989) 366-370.
43. [43] A. Segalla, personal communication, 1995.
44. [44] M.V. Agrez, R.E. Wharen, R.E. Anderson, E.R. Laws and D.M. Ilstrup, Hematoporphyrin derivative, quantitative uptake in DMH induced murine colo-rectal carcinoma, J. Surg. Oncol., 24 (1983) 173-176.
45. [45] T. Schroder, I.-W. Chen, M. Sperling, R.H. Bell, K.A. Bracklett and S.N. Joffe, Haematoporphyrin uptake and photodynamic therapy in pancreatic carcinoma, in ELA Secretariat Academic Medical Center (ed.), Proc. European Laser Association, Amsterdam, November 1986, Abstract No. 63.
46. [46] C.J. Tralau, A.J. MacRobert, P.D. Coleridge-Smith, H. Barr and S.G. Bown, Photodynamic therapy with phthalocyanine sensitization: quantitative studies in a transplantable fibrosarcoma of rats, Br. J. Cancer, 55 (1987) 389-395.
47. [47] C.J. Tralau, H. Barr, D.R. Sandeman, T. Barton, M.R. Lewin and S.G. Bown, Aluminum sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas, Photochem. Photobiol., 46 (1987) 777-781.
48. [48] A.R. Morgan, G.M. Garbo, T. Krivak, M. Mastroianni, N. Petousis, T. St Clair, M. Wiesenberger and J.E. van Lier, New photosensitizers for PDT, in T.J. Dougherty (ed.), Optical Methods for Tumor Treatment and Early Diagnosis: Mechanisms and Techniques, Proc. SPIE, 1426 (1991) 350-355.
49. [49] Q. Peng, J. Moan, L.-W. Ma and J.M. Nesland, Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphyrin and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma, Cancer Res., 55 (1995) 2620-2626.
50. [50] C.R.J. Singer, D.C. Linch, S.G. Bown, E.R. Huehns and A.H. Goldstone, Differential phthalocyanine photosensitization of acute myeloblastic leukemia progenitor cells: a potential purging technique for autologous bone marrow transplantation, Br. J. Haematol., 68 (1988) 417-422.